CVRx, Inc. Files Form 8-K: Adoption of New Performance Stock Unit Agreement for Executives

MINNEAPOLIS, March 3, 2026 – CVRx, Inc. (NASDAQ: CVRX), a medical device company based in Minneapolis, has submitted a Form 8-K to the U.S. Securities and Exchange Commission announcing the introduction of a new Performance Stock Unit (PSU) Agreement for its executives, linked to cumulative revenue performance over the 2026-2027 period. This filing is pursuant to the company’s 2021 Equity Incentive Plan.

Key Points from the Report

• Performance Stock Unit (PSU) Agreement for Executives: The company has adopted a new form of PSU Agreement that directly ties executive compensation to the achievement of cumulative revenue goals over a two-year period (2026-2027).
• Eligibility and Structure: The agreement is targeted at executives and is designed to incentivize performance by awarding shares based on the achievement of pre-defined revenue milestones.
• Cumulative Revenue Goals: The number of PSUs that vest is determined by the company’s cumulative revenue for the performance period, as measured under U.S. GAAP, with adjustments to exclude the effects of accounting changes and revenues from acquisitions.
• Vesting and Settlement: 50% of achieved PSUs vest at the end of the performance period. All vested PSUs are settled in shares, subject to withholding tax obligations, which will be satisfied by a mandatory sale of a portion of the shares (a “sell to cover” mechanism).
• Mandatory Sell-to-Cover for Withholding Taxes: As a condition of the award, executives must allow a portion of their vested shares to be sold automatically to cover tax withholding obligations. This process is structured to comply with Rule 10b5-1(c) under the Exchange Act.
• No Dividend or Dividend Equivalents: The PSUs do not entitle holders to dividends or dividend equivalents during the vesting period.
• Committee Discretion: The Compensation Committee has the authority to adjust the performance goals and the number of PSUs vested up or down, including to zero, after the end of the performance period, to prevent dilution or unintended windfalls.
• Emerging Growth Company Status: CVRx continues to be classified as an emerging growth company under SEC regulations, which may impact its reporting obligations and access to certain regulatory accommodations.
• No Right to Continued Employment: The agreement explicitly states that it does not guarantee continued service or employment for executives.

Potentially Price-Sensitive Information for Shareholders

• Alignment of Executive Incentives: By linking executive compensation directly to cumulative revenue, the company is aiming to closely align management interests with those of shareholders. If revenue goals are met or exceeded, executives will be rewarded, potentially driving stronger business performance.
• Committee Discretion Over PSU Awards: The committee’s ability to adjust PSU awards up or down after the performance period introduces an element of unpredictability regarding the final number of shares issued. Large upward or downward adjustments could be material to both executives and shareholders.
• Mandatory Share Sales Could Impact Stock Price: The “sell to cover” mechanism will result in automatic sales of stock by executives when PSUs vest, which could create short-term selling pressure on the company’s shares around vesting dates.
• No Dividend Rights on PSUs: Since PSUs do not pay dividends, executives will only benefit from share price appreciation and not from any distributions, which may affect how they prioritize growth versus income strategies.
• Committee’s Sole Discretion: The Compensation Committee’s right to adjust awards—including reducing them to zero—could affect the perceived value of the equity compensation to executives and may influence retention and morale if not managed carefully.

Details of the PSU Performance Goals

• Performance Period: 2026-2027.
• Vesting Schedule: 50% of achieved PSUs vest as of December 31, following the performance period.
• Linear Interpolation: If actual performance falls between two pre-set levels, the number of PSUs vested will be determined using linear interpolation.
• Adjustments: Cumulative revenue will be adjusted to exclude certain items such as revenue from acquisitions and changes in accounting principles.
• Final Determination: The Committee will determine the final number of PSUs that vest after the performance period, with the authority to make discretionary adjustments.

Shareholder Considerations

This new PSU agreement is a significant development for shareholders, as it demonstrates CVRx’s commitment to driving top-line growth and aligning executive interests with long-term shareholder value. However, it also introduces some risks and uncertainties:

• If revenue goals are not met, executives may receive no PSU payouts, potentially impacting retention or morale.
• The automatic share sales for tax withholding could result in periodic volume spikes and downward pressure on the share price at vesting times.
• The committee’s ability to adjust PSU awards introduces a level of subjectivity that may not be fully transparent to shareholders.

Other Notable Information

• CVRx’s common stock continues to trade on the NASDAQ Global Select Market under the symbol CVRX.
• No changes to the company’s financial reporting obligations or capital structure were disclosed in this filing.
• The company remains an “emerging growth company,” enjoying certain reduced reporting requirements under SEC rules.

Disclaimer: The information in this article is based on public filings made by CVRx, Inc. with the SEC and is intended for informational purposes only. It does not constitute investment advice or a solicitation to buy or sell any securities. Investors should review the original SEC filings and consult with financial advisors before making investment decisions. The article may contain forward-looking statements subject to risks and uncertainties.

View CVRx, Inc. Historical chart here